140 results
Page 3 of 7
8-K
EX-99.1
k41vy3uq
27 Sep 22
Other Events
9:28am
425
tph5jr9wvzmjxav e3b
26 Sep 22
Business combination disclosure
5:29pm
8-K
EX-99.3
v0j87 3vjf
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
fwk62wf9
7 Sep 22
Business combination disclosure
5:00pm
425
y3woflzipywownz
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
12uf2mzkcblvelfs6z
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
hq2jtamzwq1109 fq
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.2
md0xrxl rhp3fvbly9r8
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
jy1lfqf tvu8827
15 Aug 22
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
4:22pm
8-K
EX-99.1
hru2onnf
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm
8-K
0mcsr7oy6rzc8elak
9 May 22
Other Events
8:06am
8-K
l8ax1bc
25 Apr 22
Other Events
8:05am
8-K
EX-99.1
d5qhdi5w7kj061g
23 Mar 22
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
4:05pm
8-K
EX-99.1
jnw67b a4014
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
EX-99.1
pmtfae5pi
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
EX-99.1
wzsyi
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am